FIELD: medicine, cardiology, pharmacy. SUBSTANCE: invention proposes a novel preparation with cardiotonic activity. Invention proposes the synthetic analog of enkephalins DAGO of the following composition: D-Ala-2'-N- -Me-Phe-4'-6-Lu-5-oL-enkephalin. Effect of this preparation directs on stimulation of cardial μ-opiate receptors. EFFECT: broadened spectrum of agents of indicated prescription. 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ARRHYTHMIC AGENT | 2004 |
|
RU2260442C1 |
PREPARATION FOR TREATING ARRHYTHMIA | 1998 |
|
RU2163807C2 |
ANTI-ARRHYTHMIC AGENT | 2003 |
|
RU2235553C1 |
ANTIANGINAL AGENT | 2001 |
|
RU2200026C2 |
ANTIARRHYTHMIC AGENT | 1998 |
|
RU2171115C2 |
METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS | 2002 |
|
RU2226097C2 |
METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
AGENT IMPROVING BLOOD SUPPLY AND MYOCARDIAL METABOLISM | 2002 |
|
RU2225201C2 |
METHOD FOR DIAGNOSING THE CASES OF CHRONIC CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2200951C2 |
ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
Authors
Dates
2001-03-10—Published
1998-06-08—Filed